chartexchange

Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

Business Wire | Nov 5, 2026 8:00 AM EST

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today announced that it will report its third quarter 2026 financial and operating results on November 12, 2026, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on November 12, 2026, at 4:30 p.m. Eastern Time/1:

Read original article